Livermore
Earnings callsUse CasesNewsDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Livermore

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

IOVA

IOVANCE BIOTHERAPEUTICS, INC.

CIK 0001425205 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$8.01
↓ 0.25 (-3.03%)
as of Aug 28, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options

Key stats

Market Cap
$3.63B
P/E Ratio
-12.53
EPS
-1.09
Dividend Yield
Not covered
52W Position
82%
Beta
1.27

Valuation multiples

Fwd P/E
Not covered
PEG
0.00
P/B
4.93
P/S
11.17
EV/Revenue
10.82
ROE
-39.3%
Valuation data covers 8,744/9,719 US-listed stocks (90.0%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 82%
$1.76$9.36

Latest Financials

2025-12-31 FY
Revenue
$263.50M
Net Income
-$390.98M
Total Assets
$913.17M
Free Cash Flow
-$336.24M

Recent news